PROK
NASDAQ · Biotechnology
Prokidney Corp
$1.90
+0.02 (+1.06%)
Open$1.90
Previous Close$1.88
Day High$1.91
Day Low$1.86
52W High$7.13
52W Low$0.54
Volume—
Avg Volume571.1K
Market Cap567.69M
P/E Ratio—
EPS$-0.51
SectorBiotechnology
Analyst Ratings
Buy
15 analysts
Price Target
+943.2% upside
Current
$1.90
$1.90
Target
$19.82
$19.82
$13.43
$19.82 avg
$25.07
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.00M | 45.98M | 42.93M |
| Net Income | -153,873,041 | 9.61M | 10.78M |
| Profit Margin | -7,725.2% | 20.9% | 25.1% |
| EBITDA | -353,400,065 | 17.18M | 13.92M |
| Free Cash Flow | — | 13.69M | 9.06M |
| Rev Growth | — | +20.4% | +3.7% |
| Debt/Equity | 0.00 | 0.62 | 0.57 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |